MTOR and prostate carcinoma: Our analyses pinpoint histone deacetylases (HDAC), protein kinase A (PKA), PI3K/mTOR, and Janus Kinase (JAK) as key collateral sensitivities to Snail-mediated enzalutamide resistance in prostate cancer cells.